Information Links
Mims
Main Navigation
Drugs
Conditions
Travel
ArticlesCardiovascular news
New MIMS table summarises dosing of novel oral anticoagulants for stroke prevention
GPs can now consult a handy MIMS table to help them...
GPs should no longer prescribe 18 'low value' treatments, NHS England rules
NHS England believes cutting access to the treatments,...
Prescribe quinine with caution in patients at risk of QT prolongation, MHRA advises
New advice highlights that quinine can have effects...
Warfarin interaction warning for miconazole oral gel
Miconazole oral gel should be prescribed with caution...
Stopping statins after stroke linked to higher risk of recurrent stroke
Patients who stop statin therapy 3 to 6 months after...
Anticoagulant linked to rare calciphylaxis risk
Calciphylaxis, a rare but serious condition causing...
Selexipag: new class of treatment for pulmonary artery hypertension reaches prescribers
Uptravi (selexipag), a prostacyclin receptor agonist...
NICE approval for new class of lipid-lowering drugs
NHS clinicians must now have the option to prescribe...
Update: GPs warned about error in cardiovascular risk calculator
GPs have been advised not to use the QRISK2 cardiovascular...
'Innovative' heart failure treatment approved by NICE
A new type of drug to treat heart failure, which could...
Ticagrelor approved for long-term treatment following MI
The antiplatelet treatment Brilique (ticagrelor) can...
New once-daily fibrate/statin combination
Prescribers now have the option to prescribe fenofibrate...
Ezetimibe licensed to reduce the risk of cardiovascular events
Ezetrol (ezetimibe) can now be prescribed to reduce...
Spironolactone hyperkalaemia warning over co-administration
Monitoring of blood electrolytes is essential when...
First reversal agent available for non-coumarin oral anticoagulant
Idarucizumab (Praxbind) rapidly reverses the anticoagulant...
Entresto (sacubitril/valsartan): new heart failure combination tablet 'could replace ACE inhibitors as mainstay of treatment'
A combination of valsartan and the new drug sacubitril...
Nicorandil use restricted over ulceration risk
The anti-anginal nicorandil must only be used when...
New injectable antibody alirocumab enhances lipid-lowering effect of statins
Praluent (alirocumab) is the second lipid-lowering...
New lipid-lowering antibody evolocumab provides additional benefit to statins
Evolocumab (Repatha) is the first in a new class of...
First approved treatment for severe orthostatic hypotension
Midodrine (Bramox) provides prescribers with a licensed...
MIMS Product Slides
Product overviews prepared by the MIMS team, in a handy slide format.
Slides are initiated, funded & reviewed by the companies specified.
MIMS Clinics
Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.
